This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Progesterone is a natural reproductive hormone that ...
HRT can also be a concern after treatment. If you’ve been treated for HR+ breast cancer, “There is always some small risk ...
Progesterone Receptor Positive (PR+) breast cancer is a distinct biological subtype of hormone receptor positive breast cancer. This type of cancer grows in response to progesterone, a hormone that is ...
Breast cancer risk is a central concern in shared decision-making when considering menopausal hormone treatment (MHT). Women spend approximately 40% of their lives in menopause, and climacteric ...
Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for ...
Prognostic profiling of hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors beyond progression (BP): A synthetic control arm biomarker ...
A healthy menstrual cycle depends on a balance between estrogen and progesterone. Estrogen stimulates the growth of the ...
Menopausal hormone replacement therapy (MHT) was once routinely used to relieve symptoms of menopause and protect against ...
On World Cancer Day, doctors explain why long gaps between periods shouldn't be ignored. Infrequent menstruation can signal hormonal imbalance and raise uterine cancer risk, and early awareness can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results